Quality of life analysis of HPV-positive oropharyngeal cancer patients in a randomized trial of reduced-dose (rdCRT) versus standard (sdCRT) chemoradiotherapy: Five-year follow-up.

Mai Takahashi,Michael Hwang,Krzysztof Misiukiewicz,Richard L. Bakst,Brett A. Miles,Vishal Gupta,Marcelo Bonomi,Sonam Sharma,John Botzler,Eric M. Genden,Erin Moshier,Isaiah Selkridge,Marshall R. Posner

Quality of life analysis of HPV-positive oropharyngeal cancer patients in a randomized trial of reduced-dose (rdCRT) versus standard (sdCRT) chemoradiotherapy: Five-year follow-up.

2021

Mai Takahashi
Michael Hwang
Krzysztof Misiukiewicz
Richard L. Bakst
Brett A. Miles
Vishal Gupta
Marcelo Bonomi
Sonam Sharma
John Botzler
Eric M. Genden
Erin Moshier
Isaiah Selkridge
Marshall R. Posner

6062Background: Human papillomavirus-positive oropharyngeal cancer (HPV OPC) portends a more favorable prognosis compared to HPV-negative cases. To prevent overtreatment, long-term morbidity and de...

Keywords:

Chemoradiotherapy
Medicine
reduced dose
Internal medicine
Randomized controlled trial
Oncology
favorable prognosis
HPV-positive oropharyngeal cancer
Cancer
five year follow up
Quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations